ARTICLE | Company News
Agilis Biotherapeutics, Intrexon deal
January 6, 2014 8:00 AM UTC
On Dec. 31, 2013, Agilis and Intrexon partnered to develop DNA-based gene therapies and genetically modified cell therapies for Friedreich's ataxia (FRDA), a rare neurodegenerative disease caused by a...